Congress, Conferences & Seminars#

Development of Metabolome-Based Predictors of Liver Diseases. Cristina Alonso, Enara Arretxe, Marta Iruarrizaga-Lejarreta, Itziar Mincholé, Rubén Gil-Redondo, Ibon Martínez-Arranz, VALDIG Conference, Ascona (Switzerland), 19-22 February, 2017.

Noninvasive Serum Biomarkers Reflect the Effect of Aramchol on Mice Fibrotic Livers. Marta Iruarrizaga-Lejarreta, Laura delaCruz-Villar, Marta Varela-Rey, Rebeca Mayo, Ibon Martínez-Arranz, David Fernández-Ramos, Liat Hayardeny, Cristina Alonso, Juan Anguita, M. Luz Martínez-Chantar, José M Mato, The International Liver CongressTM, Amsterdam, the Netherlands, 19-23 April, 2017.

Metabolomics Approach Addresses the Heterogeneity of NAFLD and Determines Subtypes Associated with Different Metabolic Alterations. Marta Iruarrizaga-Lejarreta, Laura delaCruz-Villar, Marta Varela-Rey, Rebeca Mayo, Ibon Martínez-Arranz, David Fernández-Ramos, Liat Hayardeny, Cristina Alonso, Juan Anguita, M. Luz Martínez-Chantar, José M Mato, The International Liver CongressTM, Washington DC, United States, 20-24 October, 2017.

Genetic Algorithms Reveal Potential to Stratify MASKD heterogeneity. Ibon Martinez-Arranz, Dr. Cristina Alonso, Dr. Rebeca Mayo, Ruben Gil-Redondo, Itziar Mincholé, Alejandro Montilla, Óscar Millet, Mazen Noureddin, Dr. Shelly Lu, Dr. Nicholas Davidson and Prof. José M Mato, The International Liver CongressTM, Boston, United States, 10-14 November, 2023.